Heartburn Drugs May Be In Short Supply At Local Pharmacy

Zantac and others heartburn and acidreflux medications have been recalled because more time is needed to study their alleged cancer link

Wednesday, May 6, 2020 - Maybe you wandered into a CVS or Rite Aid recently looking for your favorite brand of antiacid, Zantac, and were surprised to see that there was a blank shelf where the drug is usually stocked. Nowadays one might confuse space with people hoarding the product anticipating shortages due to the Coronavirus lockdown and economic slowdown. People can be somewhat relieved to learn, however, that the drug is not being hoarded but has been recalled by the US Food and Drug Administration because it has been found to contain, under certain conditions, dangerously high levels of NDMA, a known carcinogen given to laboratory animals to produce tumors to study. Experts fear that cancer-causing compounds that are usually too small to be concerned with grow exponentially when the drug is exposed to certain environmental changes like high heat (five days at 70 degrees Celsius (158 degrees Fahrenheit) as well as when the drug mixes with nitrates (meat preservatives) in the stomach. Zantac cancer attorney lawsuits are handled by top national attorneys offering a free consultation with no obligation to file a claim.

Online pharmaceutical dispensary Valisure found the excessive levels of NDMA in Zantac while doing a routine test on the drug. According to the company, Valisure "sells the same meds that all American pharmacies use, but first put the batches through rigorous chemical analysis so the bad batches are screened out. We summarize our analytics in an easy-to-understand certificate of analysis specific to that batch." Valisure found levels of NDMA thousands of times greater than the 0.096 micrograms or 0.32 parts per million (ppm) million that the FDA considers safe.

Before the recall, Zantac was the world's leading-selling antacid drug with billions of dollars in sales each year. Zantac's manufacturer Sanofi immediately withdrew the product from store shelves before being forced to do so by the FDA to limit any further damage to people's health as the company needed time to analyze the recent NDMA cancer data. If you are wondering what to do, the FDA has recommended switching to antacid drugs that have not testes positive for NDMA such as Pepcid, Prilosec, and Nexium, however, lawsuits were filed against their respective manufacturers the other day by plaintiffs that have allegedly suffered kidney damage and osteoporosis from taking those drugs.

Individuals that are reliant on antacid drugs should speak with their physicians immediately and consider dietary and lifestyle modification that may ease their digestive discomfort without drugs. Start with reducing or eliminating the intake of coffee, alcohol, processed meats, and all spicy foods, and indigestion should be immediately greatly improved. If you or a loved one have developed stomach, bladder, prostate or other gastro-intestinal cancer having taken Zantac or other antacid or acid reflux medication regularly for years, you may consider speaking with a Zantac cancer lawers as over 17,000 people have filed suit against antiacid drugmakers since the cancer revalations first surfaced.

More Recent Heartburn MedicineLawsuit News:

• Zantac Cancer Trials Are In Discovery To Begin In October 2022 | 7/19/2022
• Zantac Cancer Lawsuits Could Hinge On The Validity of Ranitidine Testing Methods | 7/11/2022
• Zantac Cancer Bellwether Trials In California Could Set The Stage For A Global Settlement Offer | 7/5/2022
• The FDA Recommended Protein Pump Inhibitor Drugs Like Prilosec And Nexium That May Damage Health More Than Zantac | 6/23/2022
• Truck Drivers, Firefighters, and Police Officers May Have Taken More Zantac Than People In Other Occupations | 6/20/2022
• Scientists Are Expected To Confirm That Ranidine Causes Gastrointestinal Cancer With Slam Dunk Testimony | 6/9/2022
• Scientific Hearings Will Start This September To Interview Zantac Cancer Expert Witnesses | 5/19/2022
• A Whistleblower Scientist Working For A Chinese Company Thinks NDMA Contamination Started In China | 5/12/2022
• Valisure's String Of Stunning Success Casts Doubt On The FDAs Ability To Police The Health Care Market | 5/2/2022
• Zantac Testing Accusations Heat Up With FDA Investigation Of Online Prescription Drug Testing Lab | 4/25/2022
• Study Finds Ranitidine Degrades Into 10,000 Nanograms of NDMA When Introduced To Simulated Stomach Conditions | 4/6/2022
• Potential Zantac Expert Witnesses Are Being Questioned By Zantac Defense Attorneys | 3/31/2022
• The FDA Requires That Drug Companies Regularly Test Ranitidine And Other Drug For NDMA | 3/24/2022
• Update: Where The Zantac Cancer Multidistrict Litigation (MDL) Stands Today | 3/12/2022
• Zantac Cancer Plaintiffs Look To The First Trial In October In Alameda California | 3/11/2022
• Zantac Cancer Plaintiffs Have Until June 30 To Finalize Their Claim | 3/7/2022
• Zantac Bellwether Trials May Focus On Ranitidine Testing Methods That Could Cause NDMA To Accelerate | 3/1/2022
• Valisure LLC's Motivations And Ranitidine Testing Methods May Not Be Scrutinized Before Trial | 2/24/2022
• Zantac Lawsuits May Go To Trial In California In October Of This Year | 2/18/2022
• Sanofi's History Of Reprehensible Corporate Behavior May Bolster Zantac Cancer Lawsuits | 2/10/2022

Lawyers for Zantac Heartburn Medicine Lawsuits

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The Onder Law Firm has won more than $300 million in four talcum powder ovarian cancer lawsuits in St. Louis. Law firms throughout the nation often seek its experience and expertise on complex litigation.